Previous studies have shown that CNR2 is significantly up-regulated in a variety of tumor tissues, including melanoma 87, gliomas 88, glioblastoma 89, hepatocellular carcinoma (HCC) 90 and non-small-cell lung cancer (NSCLC) 91. This evidence concerns the gene CNR2 and non-small cell lung carcinoma.